Acupoint catgut-embedding therapy as promising treatment for non-alcoholic fatty liver disease

Abstract

To investigate the effect of acupoint catgut-embedding therapy on non-alcoholic fatty liver disease (NAFLD). Twenty-three participants were subjected to acupoint catgut-embedding therapy for 3 sessions. The second session was performed one month after the first session and the third session two months after the second session. Three months after the third session of catgut-embedding therapy, the patients were subjected to fibroscan analysis. A total of 20 acupoints were selected in three sessions. Same acupoints were selected for all the patients at the same session but different points were selected at different sessions. Of the 23 participants, 5 cases showed significant improvement and 8 cases showed moderate improvement as the steatosis stage was reduced by 1 or 2 degrees. The whole group showed significant improvements in terms of patient score, fat percentage, NAFLD steatosis stage, weight loss and abdominal circumference reduction after acupoint catgut-embedding therapy (all P<0.05). The acupoint catgut-embedding therapy can significantly improve the important factors in patients with NAFLD.